Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
---|---|---|---|---|---|---|
Filed 2025-01-29 19:39 Tx date 2025-01-27 |
$MIST
Milestone Pharmaceuticals Inc. |
Muller, Lorenz Andrew
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Stock Units
56 - Grant of rights
|
+80,400 vol |
80,400 | |
Filed 2025-01-29 19:38 Tx date 2019-05-13 |
$MIST
Milestone Pharmaceuticals Inc. |
Muller, Lorenz Andrew
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Stock Units
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2025-01-29 19:38 Tx date 2025-01-27 |
$MIST
Milestone Pharmaceuticals Inc. |
Muller, Lorenz Andrew
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+120,600 vol |
782,056 | |
Filed 2023-04-28 13:11 Tx date 2023-04-27 |
$MIST
Milestone Pharmaceuticals Inc. |
Muller, Lorenz Andrew
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$20,891
+5,500 vol $3.80 each |
133,386 | |
Filed 2023-04-28 13:11 Tx date 2023-04-27 |
$MIST
Milestone Pharmaceuticals Inc. |
Muller, Lorenz Andrew
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$26,498
+7,000 vol $3.79 each |
127,886 | |
Filed 2023-04-28 13:10 Tx date 2023-04-27 |
$MIST
Milestone Pharmaceuticals Inc. |
Muller, Lorenz Andrew
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$20,514
+5,500 vol $3.73 each |
120,886 | |
Filed 2023-04-28 13:10 Tx date 2023-04-27 |
$MIST
Milestone Pharmaceuticals Inc. |
Muller, Lorenz Andrew
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$26,023
+7,000 vol $3.72 each |
115,386 | |
Filed 2023-02-20 11:08 Tx date 2023-02-16 |
$MIST
Milestone Pharmaceuticals Inc. |
Muller, Lorenz Andrew
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+105,000 vol |
661,456 | |
Filed 2022-03-24 10:33 Tx date 2022-03-21 |
$MIST
Milestone Pharmaceuticals Inc. |
Muller, Lorenz Andrew
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+160,000 vol |
556,456 | |
Filed 2021-03-29 12:01 Tx date 2021-03-24 |
$MIST
Milestone Pharmaceuticals Inc. |
Muller, Lorenz Andrew
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+200,000 vol |
396,456 | |
Filed 2020-08-27 10:48 Tx date 2020-08-26 |
$MIST
Milestone Pharmaceuticals Inc. |
Muller, Lorenz Andrew
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$8,778
+5,700 vol $1.54 each |
108,386 | |
Filed 2020-08-27 10:47 Tx date 2020-08-26 |
$MIST
Milestone Pharmaceuticals Inc. |
Muller, Lorenz Andrew
5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-8,778
-5,700 vol $1.54 each |
196,456 | |
Filed 2020-06-08 16:34 Tx date 2020-06-05 |
$MIST
Milestone Pharmaceuticals Inc. |
Muller, Lorenz Andrew
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+35,000 vol |
202,156 | |
Filed 2020-06-08 16:33 Tx date 2020-04-03 |
$MIST
Milestone Pharmaceuticals Inc. |
Muller, Lorenz Andrew
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
+18,043 vol |
102,686 | |
Filed 2020-06-08 16:32 Tx date 2020-04-03 |
$MIST
Milestone Pharmaceuticals Inc. |
Muller, Lorenz Andrew
5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-27,786.22
-18,043 vol $1.54 each |
167,156 | |
Filed 2020-06-08 16:31 Tx date 2020-04-03 |
$MIST
Milestone Pharmaceuticals Inc. |
Muller, Lorenz Andrew
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
+32,528 vol |
84,643 | |
Filed 2020-06-08 16:31 Tx date 2020-04-03 |
$MIST
Milestone Pharmaceuticals Inc. |
Muller, Lorenz Andrew
5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-50,093.12
-32,528 vol $1.54 each |
185,199 | |
Filed 2020-06-08 16:30 Tx date 2019-10-01 |
$MIST
Milestone Pharmaceuticals Inc. |
Muller, Lorenz Andrew
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
+2,500 vol |
52,115 | |
Filed 2020-06-08 16:29 Tx date 2019-10-01 |
$MIST
Milestone Pharmaceuticals Inc. |
Muller, Lorenz Andrew
5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-3,850
-2,500 vol $1.54 each |
157,727 | |
Filed 2020-01-28 21:16 Tx date 2020-01-23 |
$MIST
Milestone Pharmaceuticals Inc. |
Muller, Lorenz Andrew
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+60,000 vol |
220,227 | |
Filed 2020-01-27 12:09 Tx date 2020-01-23 |
$MIST
Milestone Pharmaceuticals Inc. |
Muller, Lorenz Andrew
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+60,000 vol |
||
Filed 2020-01-27 12:09 Tx date 2020-01-23 |
$MIST
Milestone Pharmaceuticals Inc. |
Muller, Lorenz Andrew
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+60,000 vol |
220,227 | |
Filed 2019-05-22 16:38 Tx date 2019-05-13 |
$MIST
Milestone Pharmaceuticals Inc. |
Muller, Lorenz Andrew
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
160,227 | ||
Filed 2019-05-22 16:37 Tx date 2019-05-13 |
$MIST
Milestone Pharmaceuticals Inc. |
Muller, Lorenz Andrew
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
49,615 |